Enoxaparin Shows Safety in Angioplasty – STEEPLE Study
Gilles Montalescot
The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
[audio:https://www.audiomedica.com/podcasting/15.Gilles_Montalescot-The_STEEPLE_trial_randomised_more_than_3500_elective_angioplasty_patients.mp3]